1 AIDS EPIDEMIC IN COTE DIVOIRE TCHOMIAN Clement ADJE Technical Advisor, for care and support EGPAF.

Slides:



Advertisements
Similar presentations
Planning for Transition from Opti on B to B+: Rwanda Experience MUGWANEZA Placidie, Coordinator of HIV prevention Unit/RBC/MOH ART in pregnancy, breastfeeding.
Advertisements

Closing the MGD Gap Through Health Literacy Working With Civil Society and Communities Dr Bernhard Schwartländer ECOSOC Annual Ministerial Review Regional.
Scaling up HIV services for women and children achievements and challenges e-lluminate session e-lluminate session Yves Souteyrand 2 March 2010.
St Marys Hospital Ingrid V. Bassett, MD, MPH Massachusetts General Hospital Harvard Medical School May 25, 2010 Who Starts ART in Durban, South Africa?
HIV/AIDS in Brazil at a glance 11th Advanced HIV Course 1 – 3 September 2013, Aix-en-Provence, France Ana Flor Hexel Cornely Clinical Hospital, Porto Alegre.
1 TREATMENT AND PREVENTION SCALE-UP: THE SOUTH AFRICAN EXPERIENCE By Dr Moolman Team South Africa.
HIV in Brazil Ana Paula Pfitscher Cavalheiro
Italian HIV/AIDS situation 8th Advanced HIV Course -Montpellier, France 8-10 September 2010 Alessia Uglietti San Matteo Hospital, Pavia Carmela Calbi Spallanzani.
9th EACS ADVANCED HIV/AIDS COURSE AIX-EN-PROVINCE 7-9th September Dr KANHON SERGE Conseiller technique Soin et traitement PNPEC/MSLS CAP-VERT du 14 au.
HIV Situation in India Dr Sunil Gaikwad.
HIV/AIDS in Ethiopia Daniel Yilma Jimma Univeristy, Ethiopia.
1 July 2008 e Global summary of the AIDS epidemic, December 2007 Total33 million [30 – 36 million] Adults30.8 million [28.2 – 34.0 million] Women15.5 million.
2008 Report on the global AIDS epidemic Report on the global AIDS epidemic A global view of HIV infection 33 million people [30–36 million] living.
Estimating and Projecting National HIV/AIDS Epidemics UNAIDS Reference Group on Estimates, Models and Projections.
AIDS epidemic update Figure AIDS epidemic update Figure 2007 Estimated adult (15–49 years) HIV prevalence rate (%) globally and in Sub-Saharan Africa,
World Health Organization Surveys of Transmitted and Acquired HIV Drug Resistance in Resource Limited Settings CROI 2011 S Bertagnolio*, K Kelley*, A Saadani.
WHO – HIV department | February 21, |1 | November 2012 Core slides.
AIDS epidemic update Figure AIDS epidemic update Figure 2007 Estimated adult (15–49 years) HIV prevalence rate (%) globally and in Sub-Saharan Africa,
Global summary of the AIDS epidemic million [31.4 million–35.3 million] 30.8 million [29.2 million–32.6 million] 15.9 million [14.8 million–17.2.
PROCURING AND DISTRIBUTING ARVs AND OTHER A.R.T COMMODITIES IN MALAWI Technical Briefing for Consultants in Procurement and Supply Management for HIV,
Group III: Demand Forecasting
Harmonization of Reporting Requirements Tanzania
No Goals at Half-time: What Next for the Millennium Development Goals? Goal 6: Combating HIV/AIDS, malaria and other diseases John Porter.
How Universal will Universal Access be in Europe by 2010? Eddy Beck Evaluation Department UNAIDS, Geneva
Antiretroviral Therapy: An HIV Prevention Strategy? Wafaa El-Sadr, MD, MPH Columbia University Harlem Hospital New York.
Hellen Muttai, MBChB, MPH Clinical Care Manager
HIV-1 drug resistance in a rural HIV clinic in Coastal Kenya. Amin Hassan KEMRI/Wellcome Trust Research Programme, Kilifi, Kenya 22 nd November 2013.
July 2014 Epi slides.
UNAIDS World AIDS Day Report | 2011
November 2012 Core slides HIV/AIDS Epidemiology Health care response.
Exploring Synergies Health Systems and Sustainability TB/HIV collaboration Alasdair Reid UNAIDS Pretoria International Multistakeholder Consultation on.
TB/HIV epidemic in the Western Cape Update 23 February 2010 Nathea Nicolay Programme Director: Health.
Using m-health strategies to improve laboratory data management in PMTCT programs m-health satellite Washington, July 23, 2012.
Size and Population Density of Botswana 2009 estimate: 1.99m 61% aged % growth rate 0.85% death rate 0.5% migration 62yrs life expectancy 60%
ARV overview and toxicity Dr Francois Venter Reproductive Health Research Unit University of the Witwatersrand.
HIV/AIDS DEPARTMENT 2013 Consolidated ARV Guidelines Treatment Recommendations for Pregnant and Breastfeeding Women: Critical Issues Dr. Nathan Shaffer.
KZN STUDY –UPDATE South African ART Resistance Cohort Studies (SARCS)
Dr. S.K CHATURVEDI Dr. KANUPRIYA CHATURVEDI
Children and resistance to HIV: CHIPS data Dr Katherine Boyd on behalf of Collaborative HIV Paediatric Study (CHIPS) and the UK HIV Drug Resistance Database.
Women and HIV Roundtable Discussion on the Occasion of International Women’s Day 2010 “ Equal Rights, Equal Opportunities: Progress for All” Annami Löfving,
Scaling up Prevention of Mother to Child Transmission of HIV (PMTCT): What Will it Take to Eliminate MTCT? Jessica Rodrigues Presentation for UNICEF Written.
Moving to the final chapter of the AIDS epidemic.
Moving to the final chapter of the AIDS epidemic.
HIV Therapy for the Developing World: A Global Health Challenge Harold W. Jaffe, MD Department of Public Health University of Oxford Oxford, UK.
“Testing” the Limits: HIV Counseling and Testing in Clinics, Communities, and Beyond! October 2006 USAID Mini-University Alison Surdo,
Group Discussion Guyana, The Bahamas T & T, Jamaica Barbados, Haiti Suriname, Curacao.
Models of Care for Paediatric HIV Miriam Chipimo MD MPH Reproductive Health & HIV&AIDS Manager, UNICEF, Malawi.
Introduction About HIV/AIDS in Hangzhou Hangzhou Center For Disease Control And Prevention — by Zhao Gang — by Zhao Gang.
HIV/AIDS IN PERU. Map General statistics Population million Life expectancy: Male: years Female: 75.6 years GNI billion Literacy.
EARLY CHILDHOOD OUTCOMES AT THE BOTSWANA- BAYLOR CHILDREN’S CLINICAL CENTRE OF EXCELLENCE: A REPORT TO THE WHO TECHNICAL REFERENCE GROUP ON PEDIATRIC CARE.
Scaling up HIV Paediatric care Harvard – PEPFAR Program Chalamilla Guerino
PEPFAR Investment Strategy (8 years of PEPFAR) Data source : OGAC Budget Total PEPFAR Investment: $21,285,918,291 Saving Lives : Changing the.
TB Management: A Medical Aid Perspective presented by Dr Noluthando Nematswerani.
Dr. Philippe Chiliade Technical Advisor, Clinical Care, FHI 12 August 2008 Family Health International Lessons learned and challenges in scaling up Pediatric.
Use of Routine Feedback Reports to Site and District Staff in Cote d’Ivoire Hermann Brou Annual Meeting, M&E satellite meeting Johannesburg, July 28, 2010.
Agenda Introduction- Jessica Rodrigues, IATT Paediatric Treatment Optimization- George Silberry, Senior Technical Advisor for Pediatric HIV, OGAC Optimal.
Ensuring Adherence and Retention to HIV Care and Treatment among Orphans and Vulnerable Children A Multi-Country Experience Thebisa Chaava MPH Senior Technical.
Youth HIV services: Combining prevention and treatment.
1 Scaling-up ARV Therapy in Vietnam HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Outcome of a Prevention of mother to child transmission (PMTCT ) programme following Implementation of prophylaxis for HIV infected pregnant women in Barbados:
The Family AIDS Initiative: Scaling-up Family-Based Approaches to Care and Treatment in Cote d’Ivoire Joseph Essombo, Anthony Tanoh, Toure-Penda Diagola.
Ladies and gentlemen, On behalf of my country, the Republic of Côte d’Ivoire, I want to tell you how very pleased I am to be part of this high-level meeting,
Figure 1 Inclusion criteria, exclusion criteria, and criteria for virologic failure. CDC, Centers for Disease Control and Prevention; ddC, zalcitabine;
World Health Organization
WHO 2015 GUIDELINES AND FAST TRACKING TOWARDS : Regional perspective
China 2010 UNGASS Country Progress Report
From toward HIV Elimination with Boosted-Integrated Active HIV Case Management (B-IACM) in Cambodia Dr. Penh Sun LY, Director, NCHADS Presented.
Dr AKAKI Angennes; Dr SAN Koffi / NTCP
Summary Sheet Figures and Maps
Presentation transcript:

1 AIDS EPIDEMIC IN COTE DIVOIRE TCHOMIAN Clement ADJE Technical Advisor, for care and support EGPAF

Surface area km2 / population 20m

ABIDJAN

BASILIC ND DE LA PAIX

SITUATION Prevalence: UNAIDS /WHO, 3.4% in people infected by HIV in Côte dIvoire female Majority of infected patients 15 years old and children under 14 years old. Patients treated HAART in en Death Relay to HIV

SITUATION SITUATION: 90% site integrated HIV care in the routine service Laboratories VL laboratories available Genotype test resistance 2 LABs available CD4 available in 150 sites SITES HIV Testing all the sites ( 400 sites for care and treatment and 600 sites for PMTCT

CHALENGES Integration of HIV management in all sites Eradication of HIV in pediatric care service HIV National Program financing by PEPFAR CDC and other HIV Patients often expose to drug starvation Lost of follow up about 35% of patients initiated HIV therapy BIG CHALENGES

How do we plan if we are totally dependent on international financing for our national HIV program? Drug Availability? Lack of funds? Loss to Follow-up VL in routine genotypical test

Which Gold standard of care do we want for African HIV patients? At the end of the day the difference is clear

Despite all these challenges life continues

European AIDS Clinical Society THANK YOU